Inverse relationship between viral load and genotypic resistance mutations in Korean patients with primary HIV type 1 infections

AIDS Research and Human Retroviruses

Volumn 22, Issue 11, 2006, Pages 1142-1147

  Bum, Sik Chin ^a   Choi, Juyeon ^a   Nam, Jeong Gu ^a   Mee, Kyung Kee ^a   Soon, Deok Suh ^a   Jin, Young Choi ^a   Chu, Chaeshin ^a   Sung, Soon Kim ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CORRELATION ANALYSIS; DRUG POTENCY; EVALUATION; FEMALE; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; SOUTH KOREA; SUM OF THE AVERAGE RESISTANCE MUTATION SCORE; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; KOREA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; VIRAL LOAD;

EID: 33845424000     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.1142     Document Type: Article

References (20)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-860.
2. DeGruttola V, Dix L, D'Aquila R, et al.: The relation between baseline HIV drug resistance and response to antiretroviral therapy: Re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antiviral Ther 2000;5(1):41-48.
3. Ledergerber B, Egger M, Erard V, et al.: AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study. JAMA 1999;282(23):2220-2226.
4. Kuritzkes DR: A fossil record of zidovudine resistance in transmitted isolates of HIV-1. Proc Natl Acad Sci USA; 2001;98:13485-13487.
5. Brenner B, Wainberg MA, Salomon H, et al.: Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study. Int J Antimicrob Agents 2000;16(4):429-434.
6. Little SJ, Holte S, Routy JP, et al.: Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347(6):385-394.
7. Daar ES, Moudgil T, Meyer RD, and Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324(14):961-964.
8. Menendez-Arias L, Martinez MA, Quinones-Mateu ME, and Martinez-Picado J: Fitness variations and their impact on the evolution of antiretroviral drug resistance. Curr Drug Targets Infect Disord 2003;3(4):355-371.
9. Nijhuis M, Deeks S, and Boucher C: Implications of antiretroviral resistance on viral fitness. Curr Opin Infect Dis 2001;14(1):23-28.
10. Quinones-Mateu ME and Arts EJ: Fitness of drug resistant HIV-1: Methodology and clinical implications. Drug Resist Update 2002;5:224-233.
11. Prado JG, Parkin NT, Clotet B, Ruiz L, and Martinez-Picado J: HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure. Clin Infect Dis 2005;41(5):729-737.
12. UNAIDS: 2006 Report on the global AIDS epidemic.
13. Wawer MJ, Gray RH, Sewankambo NK, et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191(9):1403-1409.
14. Dyer JR, Gilliam BL, Eron JJ Jr, Cohen MS, Fiscus SA, and Vernazza PL: Shedding of HIV-1 in semen during primary infection. AIDS 1997;11(4):543-545.
15. Yerly S, Vora S, Rizzardi P, et al.: Acute HIV infection: Impact on the spread of HIV and transmission of drug resistance. AIDS 2001;15(17):2287-2292.
16. Grant RM, Hecht FM, Warmerdam M, et al.: Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002;288(2):181-188.
17. Simon V, Vanderhoeven J, Hurley A, et al.: Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS 2002;16(11):1511-1519.
18. U.K. Collaborative Group on Monitoring the Transmission of HIV Drug Resistance: Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001;322(7294):1087-1088.
19. Bezemer D, Jurriaans S, Prins M, et al.: Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS 2004;18(11):1571-1577.
20. Lavreys L, Baeten JM, Overbaugh J, et al.: Virus load during primary human immunodeficiency virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Clin Infect Dis 2002;35(1):77-81.